BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36794976)

  • 1. Porocarcinoma with YAP1-NUTM1 fusion presenting as a NUT immunohistochemistry-positive lymph node metastasis.
    Christensen DJ; Tuluc M
    J Cutan Pathol; 2023 May; 50(5):410-414. PubMed ID: 36794976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
    Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
    Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
    Russell-Goldman E; Hornick JL; Hanna J
    J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
    Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
    Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
    Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
    J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor.
    Agaimy A; Stoehr R; Tögel L; Hartmann A; Cramer T
    Head Neck Pathol; 2021 Mar; 15(1):361-367. PubMed ID: 32504288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.
    Parra O; Kerr DA; Bridge JA; Loehrer AP; Linos K
    J Cutan Pathol; 2021 Jan; 48(1):95-101. PubMed ID: 32757412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
    Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
    J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update.
    Kervarrec T; Pissaloux D; Tirode F; de la Fouchardière A; Sohier P; Frouin E; Hamard A; Houben R; Schrama D; Barlier A; Cribier B; Battistella M; Macagno N
    Histopathology; 2024 Jan; 84(2):266-278. PubMed ID: 37609771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
    Li P; Busam KJ
    J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1-deficient skin carcinoma.
    Kervarrec T; Frouin E; Collin C; Tallet A; Tallegas M; Pissaloux D; Tirode F; Guyétant S; Samimi M; Gaboriaud P; Touzé A; Schrama D; Houben R; Tabareau-Delalande F; Neuhart A; de la Fouchardière A; Osio A; Cavelier-Balloy B; Laurent-Roussel S; Sohier P; Cyprien T; Balme B; Belzung F; Jullie ML; Cribier B; Battistella M; Macagno N
    Histopathology; 2023 May; 82(6):885-898. PubMed ID: 36720791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
    Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
    J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
    Hartsough EM; Moran J; Devins K; Wszolek M; Cornejo KM
    Am J Dermatopathol; 2023 Jan; 45(1):51-55. PubMed ID: 36484607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eccrine porocarcinoma: case report and review of the literature.
    Grieco M; Simonacci F; Grignaffini E; Ricci R; Raposio E
    G Ital Dermatol Venereol; 2020 Aug; 155(4):500-504. PubMed ID: 33050682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP1-NUTM1 Gene Fusion in Eccrine Porocarcinoma with Late Metastatic Recurrence: A Case Report.
    Tormo-Mainar S; Vidal J; Salido M; Pujol RM; Deza G
    Acta Derm Venereol; 2022 Jul; 102():adv00752. PubMed ID: 35818732
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.
    Goto K; Ishikawa M; Hamada K; Muramatsu K; Naka M; Honma K; Sugino T
    Am J Dermatopathol; 2021 Nov; 43(11):781-787. PubMed ID: 33767067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
    Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
    Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
    Chen M; Chen X; Zhang Y; Wang W; Jiang L
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of eccrine porocarcinoma characterized by a progressive increase in the level of Ki-67 index: case report and review of literature.
    Shen J; Pan X; Lu Y; Pan D; Ma Y; Zhan R
    BMC Surg; 2019 Oct; 19(1):142. PubMed ID: 31601219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
    Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
    Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.